Internet Archive Scholar

Telemonitoring type 1 diabetes patients during the COVID-19 pandemic in Brazil: was it useful?

Alessandra Saldanha de Mattos Matheus, Carolina Alves Cabizuca, Lucianne Righetti Monteiro Tannus, Aline Camin Passos, Amábile Cristyne Schmidt, Ana Tarasiuk de Gouveia, Bruno Moraes de Albuquerque Pessoa, Felipe Cerqueira Matheus, Gabriela Yea-Huey Yang, Josimara Araujo da Silva Divino, Juliana Affonso Mathiles, Juliana Leite Teixeira (+4 others)
2020 Archives of Endocrinology and Metabolism  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (167.8 kB)
https://web.archive.org/web/20210428004158/http://www.scielo.br/pdf/aem/2020nahead/2359-4292-aem-2359-3997000000309.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL. The file type is application/pdf.

To evaluate the performance of telemonitoring in detecting clinical and psychological needs and adherence to the protective measures imposed by the COVID-19 pandemic in addition to providing remote assistance for patients with type 1 diabetes (T1D) in a public university center in Brazil. Telemonitoring protocol included phone calls and e-mails. Patients were asked to rate COVID-19-like symptoms, psychological symptoms, epidemiological issues, and adherence to diabetes management (insulin,
more » ... ise, and diet) using a 0-to-10 scale. An e-mail address and phone number were offered for further contact if needed. Clinical, demographic, and laboratorial data from the consultations before the pandemic were collected from medical records. Among 321 patients with a previously scheduled consultation over the first 15 weeks of social distancing, 237 (73.8%) could be successfully contacted. Of these, 207 (87.3%) were exclusively evaluated by telemonitoring (190 only by phone or text message and 17 who were also reached by email), and 30 (12.7%) patients attended the consultation for medical reasons detected during the telephone screening. Overall, 44 (18.5%) patients reported COVID-19-like symptoms. One (2.3%) patient was hospitalized and subsequently died. Psychological symptoms were reported by 137 (60.4%) patients and 30 (12.7%) required remote psychological assistance. Appropriate social distancing was performed by 203 (87.9%) patients, and 221 (97.8%) referred use of masks. Telemonitoring T1D patients during the pandemic helped reduce the need for in-person consultations, detect clinical and psychological needs, and offer support to patients in addition to monitoring suspected COVID-19 cases and the adherence to protective measures.
doi:10.20945/2359-3997000000309 pmid:33166438 fatcat:i3rv5jwfofegdlj3mnjunqkdaa
DOAJ SciELO
Citation

Alessandra Saldanha de Mattos Matheus, Carolina Alves Cabizuca, Lucianne Righetti Monteiro Tannus, Aline Camin Passos, Amábile Cristyne Schmidt, Ana Tarasiuk de Gouveia, Bruno Moraes de Albuquerque Pessoa, Felipe Cerqueira Matheus, Gabriela Yea-Huey Yang, Josimara Araujo da Silva Divino, Juliana Affonso Mathiles, Juliana Leite Teixeira, Luiza de Souza Barroso, Max Benicio da Fonseca de Brito, Paula Melichar Suassuna, Roberta Arnoldi Cobas. "Telemonitoring type 1 diabetes patients during the COVID-19 pandemic in Brazil: was it useful?." Archives of Endocrinology and Metabolism (2020)